121 - Stephen Ubl, President & CEO of PhRMA, on drug pricing, supply chains, and the industry’s miraculous Covid-19 response

A Second Opinion with Senator Bill Frist, M.D.

תוכן מסופק על ידי Bill Frist and A Second Opinion Podcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי Bill Frist and A Second Opinion Podcast או שותף פלטפורמת הפודקאסט שלו. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

3y ago 1:03:02

MP3•בית הפרקים

סדרה בארכיון ("עדכון לא פעיל" status)

When? This feed was archived on August 02, 2023 17:10 (9M ago). Last successful fetch was on June 27, 2023 13:36 (10M ago)

Why? עדכון לא פעיל status. השרתים שלנו לא הצליחו לאחזר פודקאסט חוקי לזמן ממושך.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Stephen Ubl is the president and CEO of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, which represents America's leading biopharmaceutical research companies.

The U.S. biopharmaceutical sector directly employs more than 800,000 Americans and invests more than $100 billion in research and development annually -- more than any other industry in America. Steve leads the advocacy for this industry in Washington, DC and across the country.

A policy expert with a record of enacting meaningful healthcare reform, Steve joins me today to do a deep dive on the drug industry – examining costs, the supply chain, and the industry’s unprecedented response to Covid-19.

201 פרקים

#Fitness #Government #Billfrist #Healthcare #Innovation #Medicine #Policy #Technology #Frist #Second Opinion #COVID19 #Health and Well-Being #Senate